Nutex Health (NASDAQ:NUTX) Shares Down 5.9% - Here's Why

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) fell 5.9% during mid-day trading on Wednesday . The stock traded as low as $120.70 and last traded at $123.99. 192,737 shares changed hands during mid-day trading, an increase of 127% from the average session volume of 85,057 shares. The stock had previously closed at $131.80.

Wall Street Analysts Forecast Growth

Several analysts recently commented on NUTX shares. Maxim Group raised their price objective on Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th. Wall Street Zen downgraded Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Finally, Benchmark raised their price target on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th.

Nutex Health Price Performance

The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The company's 50-day moving average price is $134.59 and its 200-day moving average price is $85.78. The company has a market cap of $663.86 million, a P/E ratio of 10.04 and a beta of -0.04.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The firm had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million.

Insider Activity

In other news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction on Tuesday, April 8th. The shares were purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer owned 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 36.92% of the company's stock.

Institutional Trading of Nutex Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Essex Investment Management Co. LLC raised its holdings in Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after acquiring an additional 33,024 shares in the last quarter. American Century Companies Inc. bought a new stake in shares of Nutex Health during the 4th quarter worth approximately $1,362,000. Geode Capital Management LLC raised its position in Nutex Health by 12.6% during the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after acquiring an additional 3,826 shares in the last quarter. World Investment Advisors acquired a new stake in Nutex Health in the 4th quarter valued at about $217,000. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Nutex Health in the fourth quarter valued at approximately $672,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.